»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ B kC(9[Ei
k4`v(au^
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806 36j.is
:q= XE$%H
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£© lF#Kg!-l
1.Antigen presenting cell£¨APC£© }KOu
2.Activation induced cell death£¨AICD£© 'DIE#l`
3.Chemokine
2R_k$kHl
4.Major histocompatibility complex£¨MHC£© nU`;MW/^w
5.immunotolerance O_:Q#
wUSWB{y
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© N1SR nJu<f
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ BujWql
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà &iSQ2a!l8b
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ jALo;PDJ
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ 4$;fj1!Z:
5.±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã eygy
VhJ
Cz(Pj S
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© SnXLj
Je
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ ,iHt*SZ,*
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ vuK 5DG4
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ PK~okz4b
_l Jj 6=
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ %:/;R
_
iUO5hdOM
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 M\]E;C'"U
oNdO@i%.q4
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ ;J_d%
1.Antigenic determinant <ImeZ'L7
2.IgSF >s>5k
O
3.MBL;¾¶ qlzL<
4.chemokine E^qKkl
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ B U)4g[4
6.TCR-CD3¸´ºÏÎï _6|b0*jv'&
7.FADD£¨Fas-associated protein with death domain£© ~:0h o
8.AIDS q}8R>`Z{
9.Tumor rejection antigen U-Iwda8v
10.AICD %AJdtJ@0H
ePF9Vzq
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ Y8N&[L[z&
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© Zs4N0N{
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ w?R6$n`
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ _7;#0B
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì BvYJ!V
j
yb]a p
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ qzH97<M}T
J0x)m2
P--#5W;^oB
רҵ¿Î ÃâÒßѧ 1b't"i M
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê *
5j iC
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell Axcm~!uf
5. Fc¦Å receptor 6. Cytokine 4[(P>`Unx
¶þ¡¢ ÎÊ´ðÌâ ;+5eE`]a/L
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØÉ±É˰Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 2yN~[,L
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ J"
z8olV
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁܰÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ avT>0b:
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâÐ©ÌØµãµÄÉúÎïѧÒâÒ壿 EBn7waBS
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦Óᣠ$}jSIn=~|t
ge E7<"m%
N".
af)5
wWH5T}\
8J@REP4
N
(43+
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 0R; ;
ou
Q2
+e`
P ^D\znvc
רҵ¿Î ÃâÒßѧ <8'}H`w%
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê e\)PGjSI
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen pE`BB{[@
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin m. XLpD
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test D VC};
9. Hybridoma technic 10.Mitogen aiz_6@Qfz*
11.Dentritic cell 12.Immunoproliferation VRT| OUq
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ 5I@< 6S&X
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨ÄöÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ ZX'/[wAN)
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦Óᣠw%`7,du|
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ mgg/i@(
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ B1\}'g8%f
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ X62GEqff
h19c*,0z!
f BukrPsV
lNqYpyvy*
<AzvVSA,
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ s<aJ pi{n4
iz&)FuOr
fyh9U_M);w
רҵ¿Î ÃâÒßѧ `cCsJm$V"
Ò»¡¢ Ãû´Ê½âÊÍ YG$Y4h"
@"
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï ]w"r4HlCx
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà )} tI8
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ r 1n l!
¶þ¡¢ ÎÊ´ðÌâ 1d"g$i4e
1¡¢ TÁܰÍϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ X`ee}C.D_
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁܰÍϸ°ûºÍЧӦÎïÖÊ¡£ ol[
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆä¹²Í¬Ìص㼰ÓëÁÙ´²µÄ¹ØÏµ¡£ j!F5gP-l
4¡¢ ºÎνÁܰÍϸ°ûÔÓ½»Áö¼¼Êõ£¬ÊÔÊöÆäÔÀí¼°ÒâÒå¡£ lmfvT}$B
5¡¢ ºÎνÉúÎïËØ-Ç׺ÍËØÏµÍ³£¿ÊÔÊöÆäÓ¦ÓÃÓÚÃâÒß±ê¼Ç¼¼ÊõµÄÔÀí£¬ÒÔABC·¨ÎªÀý˵Ã÷Ö®¡£ Rq|7$O5
a~>+I~^K5q
AAb3Jf`UW
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÎåÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ I<Wp,E9G#
Zi/tax9C
bbCH(fYbu
רҵ¿Î ÃâÒßѧ HRn
Q*
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê P%2aOsD0
1¡¢ SmIg 2¡¢ Graft-versus-host reaction GVHR 98'/
yZ
3¡¢ Immunocompent cell ICC 4¡¢ Tumor-associated antigen TAA U[,."w]T
5¡¢ Cytokine 6¡¢ Immune tolerance 7¡¢ Biological responsw modifier BRM Lyo!}T
¶þ¡¢ ÎÊ´ðÌâ 6?i]oy^X]p
1¡¢ ÃâÒßϵͳÄÚÆðɱÉËЧӦµÄϸ°ûÓÐÄÄЩ£¿ÊÔ¼òÊöÆäɱÉËЧӦµÄÌØµã¡£ lJb1{\|.,
2¡¢ ºÎν¿¹ÌåµÄ¶àÑùÐÔ£¿¿¹ÌåµÄ¶àÑùÐÔ±íÏÖÔÚÄÄЩ·½Ã棿¼òÊö²úÉú¿¹Ìå¶àÑùÐÔµÄÔÀí¡£ <NKmLAfX
3¡¢ ÊÔÊö¢òÐÍÓë¢óÐͳ¬Ãô·´Ó¦·¢Éú»úÖÆµÄÒìͬµã¡£ UTwXN |'|
4¡¢ ºÎνMHC£¿ÊÔ¼òÊöÆä¹¦ÄÜ¡£ Pu>jECcz
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¬ÒÔø±ê¼Ç¼¼ÊõΪÀý¼òÊöÆäÖ÷ÒªÔÀí¡£ MkLXMwuQ&
M~+}ss
JJe8x4
0gTv:1F/
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÁùÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ Bm"-X:='
C-)mP- |8
!$n@-
רҵ¿Î ÃâÒßѧ J,(@1R]KF:
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê H1Jk_@b
1. IgSF 2. Fc 3. Flow cytometry 4. Adhesion molecule `) y<X#[8
5. Autogous mixed lymphoyte reaction Eqizx~e qq
¶þ¡¢ ÎÊ´ðÌâ
u
:]c
1. ÊÔÊöÍâÀ´TD¿¹Ô½øÈë»úÌåÓÕµ¼¿¹Ìå²úÉúµÄÈ«¹ý³Ì¡£ {'#1do}{
2. ºÎνϸ°ûÒò×Ó£¿¼òÊöIL-2µÄ¼ì²â·½·¨¼°ÆäÔÀí¡£ +}VaQ8ti4
3. ¼òÊö¿¹¶ÀÌØÐÍÍøÂçµÄµ÷¿Ø×÷Óᣠ\rj>T6
4. ÃâÒßÓ¦´ð¶Ô»úÌåÓкÎÀûº¦¹ØÏµ£¿ QHU|aC{r
/ <C{$Gu
f`<elWgc"
~%chF/H
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÆßÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ $-=xG&fSz
Zh
!MXn&&e1
רҵ¿Î ÃâÒßѧ vmzc0J+3p
Z)&!ZlM
_lG|t6y
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê hv0bs8h
1. Idiotupe 2. Opsonization 3. Epitope 4. Immunologic tolerance CM%Rz-c
5. Delayed type hypersensitivity vX@TZet0
¶þ¡¢ ÎÊ´ðÌâ
f@@7?5fW
1. ÊÔÊö²¹Ì徵伤»î;¾¶ÓëÅÔ·¼¤»î;¾¶µÄÒìͬ¡£ $PstEL
2. ¼òÊö¿¹ÌåµÄ»ù±¾½á¹¹£¨ÒÔIgGΪÀý£©Ó빦ÄÜ¡£ Iq?n*P$
3. ¼òÊöHLAÓëҽѧµÄ¹ØÏµ¡£ hp c &s
4. ÊÔÊöµ¥ºË/¾ÞÊÉϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óᣠ$d-$dM?R5
5. ¼òÊöÃâÒßÓ¦´ðÖи÷ÖÖÀàÐ͵Äϸ°û¶¾×÷ÓᣠQ7.jSL6
)n6,uTlOw
<z#.J]
)1f%kp#]
0GlQWRa
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å°ËÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ [uwn\-
GrUpATIx
v2IcDz`}7
רҵ¿Î ÃâÒßѧ 7Ll?#eun
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê j0=F__H#@
1. hypersensitivity 2. cluster of differentiation 6FYL},.R
3. adhesion molecules 4. supper antigen 5. split tolerance /lC,5y
¶þ¡¢ ÎÊ´ðÌâ QOX'ZAB`
1. ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ÓµÄÖ÷ÒªÉúÎïѧ»îÐÔ¡£ OMW]9E
2. ¼òÊöMHC¿¹ÔµÄ·Ö×ӽṹ¼°Æä×éÖ¯·Ö²¼¡£ G4U0|^(h
3. ÊÔÊöÐØÏÙÒÀÀµÐÔ¿¹ÔÒýÆðÌåÒºÃâÒßÓ¦´ðµÄÈ«¹ý³Ì£¨°üÀ¨³õ´ÎÃâÒßÓ¦´ðºÍÔÙ´ÎÃâÒßÓ¦´ð£©¡£ ?S;z!)
H)P
4. Ϊʲô˵²¹Ì弤»î;¾¶Ö÷Òª²ÎÓëÌìÈ»ÃâÒߣ¿ÊÔÊö²¹ÌåÊÇÈçºÎ¾¹ýÅÔ·;¾¶¶ø±»¼¤»îµÄ¡£ 2 OV$M~
5. Ϊʲô¿¹Ä³Ò»Ï¸°ûÒò×ÓÊÜÌåµÄµ¥¿Ë¡¿¹ÔÌ壬ÓбíÏÖ³öÊÜÌå·â±Õ×÷Ó㬶øÓеÄÔò±íÏÖ³öÊÜÌå´Ì¼¤×÷Óã¿ {Q>4zepN!
sSf;j,7V
Oq$-*N
<ne?;P1L
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ ; GE6S{~-
רҵ¿Î ÃâÒßѧ ])G|U A.
Ò»¡¢ Ãû´Ê½âÊÍ ;HBKOe_3
1. ¿¹ÔÐÔ 2. ÃâÒßÇòµ°°×³¬¼Ò×å 3. ¶ÀÌØÐÍ 4. ¿¹Ô¾ö¶¨×å cNT !}8
h^
5. GVHR k( Ik+=u
¶þ¡¢ ÎÊ´ðÌâ CDF;cM"td
1. Á½ÖÖ²¹Ì弤»î;¾¶µÄµ÷½ÚÒò×ÓÓÐÄÄЩ£¿±È½ÏËüÃÇÁ½ÖÖ;¾¶ÖеÄ×÷Óᣠw:9`R<L
2. ¢òÐͳ¬Ãô·´Ó¦µÄ»úÀíÌØµãÊÇʲô£¿¾Ù³öÈý¸ö¢òÐͳ¬Ãô·´Ó¦µÄÀý×Ó¡£ s$zm)y5
3. ÊÔÊöϸ°ûÒò×ÓµÄ×÷ÓÃÌØµã¡£ TQ:h[6v
4. Bcell½éµ¼µÄÌåÒºÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ w2!:>8o:
5. MPSµÄÃâÒßѧ¹¦ÄÜ¡£ [NJ2rQ/w7
>Tjl?CS
}t"K(oamm
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ am!ssF5s
.N>*+U>>P
oOc-1C
y
רҵ¿Î ÃâÒßѧ S(U9Dlyarg
Ò»¡¢Ãû´Ê½âÊÍ j/Y]3RSMp
1. ÃâÒßÇòµ°°×µÄ¶ÀÌØÐÍ 2. 𤸽·Ö×Ó 3. ÃâÒßÇòµ°°×³¬¼Ò×å AbhR
*
4. ¸ÉÈÅËØ 5. HLAµÄ¶à̬ÐÔ 6. ÐØÏÙÒÀÀµÐÔ¿¹Ô 7. ÃâÒßÄÍÊÜ b%*`}B
8. ËÙ·¢Ðͳ¬Ãô·´Ó¦ 9. µ¥¿Ë¡¿¹Ìå 10. ²¹Ì徵伤»î;¾¶ *59|
11. »ìºÏÁܰÍϸ°û·´Ó¦ 12. ÓÐË¿·ÖÁÑ ]b]J)dDI
Èý¡¢ ÎÊ´ðÌâ >Ut: -}CS
1. ÊÔ¼òÊö¾ÞÊÉϸ°ûÌá³ÊTD¿¹ÔµÄ¹ý³Ì¡£ aeI0;u
2. ÊÔ¼òÊöÒÆÖ²ÎËÞÖ÷·´Ó¦µÄ·¢Éú»úÖÆ wdf;LM
3. ÊÔÊö²¹ÌåµÄÖ÷ÒªÉúÎïѧ×÷Óà ]c
v|dc=
4. ÒÔIgGΪÀý£¬ÊÔÊöÃâÒßÇòµ°°×·Ö×ӵĻù±¾½á¹¹ &o7PB`(l
5. ÊÔÊöTϸ°ûµÄÖ÷Òª±íÃæ±êÖ¾¼°¹¦ÄÜ ^|zag
lyFlJm i,r
%o4v
} mzV
K
AD2_@l
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ Cse`MP
lwgwdB
&*'^uCna
רҵ¿Î ÃâÒßѧ M;b3-
i
Ò»¡¢Ãû´Ê½âÊÍ v4Rci^ 8
1. Ig¶ÀÌØÐÍ 2. SAg 3. 𤸽·Ö×Ó 4. CSF 5. IgSF 6. Tϸ°û»î»¯µÄ´Ì¼¤·Ö×Ó Z3YKG{g
7. HLAÓë¼²²¡µÄ¹ØÁª 8. ELISA 9. ÁܰÍϸ°ûµÄ±íÃæ±êÖ¾ ?<^8,H
Èý¡¢ ÎÊ´ðÌâ ZO/Jf Jn~
1. ¼òÊöTÁܰÍϸ°ûµÄ·ÖÀ༰¹¦ÄÜ£¿ _aOs8#(X
2. ¼òÊöHLAÍ»±äÌåµÄ»ùÒò×é³É¼°HLAµÄ¹¦ÄÜ£¿ ubfh4
3. ¼òÊö»úÌå¶ÔÍâÔ´ÐÔ¿¹Ô£¨ÒìÎԣ©µÄ´¦Àí£¬ÈçIgÌá³Ê¹ý³Ì£¿ mjg@c|rTG
4. ¼òÊö²¹ÌåÁ½ÖÖ¼¤»î;¾¶µÄ»ù±¾¹ý³Ì£¬²¢±È½Ï¶þÕßÒìͬ£¿ P(Rl/eyRM
5. ¼òÊöAIDSÖÐCD4+ϸ°û¼õÉٵĻúÖÆ£¿ ilVi
0&fO)de96
L~)8Q(f
T
?f{.a)
1goRO
99Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ 1eV&oN#
Ò»¡¢Ãû´Ê½âÊÍ T(Q ~b
2¡¢ HLAµÄ¶à̬ÐÔ 3¡¢ 𤸽·Ö×Ó 4¡¢ ¶ÀÌØÐÍ 5¡¢ ¿¹ÔëÄתÔËÎï "=
%"@"<)
6¡¢ Ig³¬¼Ò×å 7¡¢ µòÍö 8¡¢ ÓÐË¿·ÖÁÑÔ 9¡¢ CD4·Ö×Ó _eq$C=3Ta
10¡¢ ³¬Ãô·´Ó¦ 11¡¢ ×ÔÉíÃâÒß²¡ bo90;7EK8
¶þ¡¢ ÎÊ´ðÌâ wMN{ 9Ce3j
1¡¢ ÊÔÊöÍâÔ´ÐÔ¿¹ÔºÍÄÚÔ´ÐÔ¿¹ÔÌá³ÊµÄ¹ý³Ì¡£ rjWtioZEa
2¡¢ ÊÔÊöBϸ°û½éµ¼µÄÔÙ´ÎÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ 60{DR >S
3¡¢ ÊÔÊö·Ö×ÓˮƽµÄÃâÒßµ÷½Ú¡£ 2jC:uk
4¡¢ ÊÔÊö»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷£¨AIDS£©µÄ·¢²¡»úÖÆ¡£ DpA)Vdj
@$^4Av-
2000Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ M_UmnqN1C
Ò»¡¢ Ãû´Ê½âÊÍ kiN,N]-V
1¡¢ µ÷Àí×÷Óà 2¡¢ 𤸽·Ö×Ó 3¡¢ ³¬¿¹Ô 4¡¢ ÃâÒßȱÏݲ¡ <_t]?XHB[
5¡¢ FasÓëFasL 6¡¢ µ¥¿Ë¡¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ ko[d axUB
8¡¢ ÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£© 9¡¢ Ö×ÁöÏà¹Ø¿¹Ô£¨TAA£© ,9jk<)m]L
10¡¢ ÒõÐÔÑ¡Ôñ {D",ao
¶þ¡¢ ÎÊ´ðÌâ U7jDm
>I
1¡¢ ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ӵĹ²Í¬Ìص㣿 56c[$ q
2¡¢ ºÎνAPC¼°ÆäÖÖÀࣿ¼òÊöÍâÔ´ÐÔ¿¹ÔµÄÈÜøÌåÌá³Ê;¾¶£¿ ?.F^Oi6
u
3¡¢ ¼òÊöϸ°ûÃâÒßÓ¦´ðµÄÁ½ÀàЧӦϸ°ûµÄЧӦ»úÖÆ£¿Ï¸°ûÃâÒßµÄÉúÎïѧÒâÒ壿 ({C[RsY=6
4¡¢ ºÎνMHC£¿¼òÊöMHCµÄ¹¦ÄÜ£¿ ^&mrY[;S
5¡¢ ºÎν×ÔÉíÃâÒß²¡£¿¼òÊö×ÔÉíÃâÒß²¡µÄ×éÖ¯ËðÉË»úÖÆ£¿. e4Qjx*[G
xSM1b5=Pu
6Sn&;ap
9)S3{i6w
ͬ¼ÃÒ½¿Æ´óѧ2000Äê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ V[*>}XQER
#prYZcHv:_
2
yANf
רҵ¿Î ÃâÒßѧ CP2wg .
Ò»¡¢½«ÏÂÁÐÓ¢Óïµ¥´Ê·Òë³ÉÖÐÎIJ¢Ãû´Ê½âÊÍ BxV>s+o&]
1. Cytokines 2. adhesion molecules 3. graft versus host reaction 1QD49)
4. immunologic tolerance 5. Opsonization 5RWqHPw+
Èý¡¢ ÎÊ´ðÌâ 6S{F4v2/0
1. ʲôÊÇMHC£¿ÊÔÊöMHC-¢òÀà·Ö×ӵĽṹ¡¢¸÷²¿Î»¹¦ÄÜ£¬MHC-¢òÀà·Ö×ÓµÄ×éÖ¯·Ö²¼¼°ÆäÃâÒßѧ×÷Óᣠu tkdL4G}'
2. ÓÐÄÄÈý´ú¿¹Ì壿ÊÔÊö¿¹Ì壨IgG£©µÄ»ù±¾½á¹¹¡¢¸÷²¿Î»¹¦Äܼ°ÕâÈý´ú¿¹ÌåµÄÌØÐÔ¡£ 0',buJncV
3. ʲôÊÇ×ÔÉíÃâÒß²¡£¿ÊÔÊöÆä·¢²¡»úÖÆ¡£ ]ke9ipj]:
4. ÃâÒßϵͳɱÉ˰Ðϸ°ûµÄ·½Ê½¼°ÏàӦϸ°ûºÍ·Ö×ÓÓÐÄÄЩ£¿ÊÔÊöTc½éµ¼µÄϸ°ûÃâÒßÓ¦´ð¡£ | Z7j
s"
5. »úÌåµÄÃâÒßϵͳΪʲô¿ÉÒÔʶ±ð×Ô¼ººÍÒ켺£¿ÆäÖ÷Òª»úÖÆÊÇʲô£¿ 6qTMHRI
B?^~1Ua9Zv
tl~ZuS/
P/WGB~NH
}{@y]DcdM4
H$WD7/
?j
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ rf]z5;
.IY@Q
Vfk"}k/do
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧרҵ¿Î¿¼ÊÔÊÔÌâ WW6-oQs_#*
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ ND.(N'/O
Ò»¡¢ ½âÊÍÏÂÁÐÃû´Ê W"vkmk
1. C3b½éµ¼µÄµ÷Àí×÷Óà 2.Tϸ°û¼¤»îµÄµÚ¶þÐźÅ3.Th1ϸ°û 4.HLAµÄ¶à̬ÐÔ $vO<v<I'Gb
5.C1ÒÖÖÆÎï 6.TCR¦Ã¦ÄTϸ°û7.³Ù·¢Ðͳ¬Ãô·´Ó¦ 8.Ç÷»¯ÐÔϸ°ûÒò×Ó9.ÃâÒßÇòµ°°×µÄÀà±ðת»¯ 10.ÔìѪ¸Éϸ°û eE
.wnn
11.»î»¯ÓÕµ¼µÄϸ°ûËÀÍö 7\yh(+ kN
¶þ¡¢ Çë»Ø´ðÏÂÁÐÎÊ´ð _s0)Dl6K
1. ºÎνµ¥¿Ë¡¿¹Ì壬¼òÊöÆäÖÆ±¸ÔÀí¡£ OMo /a%`
2. ¼òÊöTϸ°ûÔÚÐØÏÙÄڵķ¢Óý¹ý³Ì¡£ jxm#4
3. ÃâÒßϸ°û±íÃæÖ÷ÒªÓÐÄļ¸Àà±íÃæ¿¹ÔºÍ±íÃæÊÜÌ壬¼òÊö¸÷Àà·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡££¨HLA¡¢CD¡¢AM¡¢CKR¡¢CR¡¢MitogenR¡¢TCR¡¢BCR¡¢FcR£© #Q["[}flVv
4. ÊԱȽÏTCR¸´ºÏÌåºÍBCR¸´ºÏÌå½á¹¹Ó빦ÄܵÄÒìͬ¡£ 3w p@OF_
5. ÊԱȽϳ¬¿¹ÔÓëÆÕͨ¿¹ÔµÄÒìͬ¡£ g
n.)_
'CJ_&HR
_ Dz
*%
0<4'pO.6Hq
Glx{Zu=
W]bytsl
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ nB
:i G
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧµ¥¶À¿¼ÊÔÊÔÌâ JS\]|~Gd
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ ]xb2W~
>Q"3dw
Ò»¡¢ Ãû´Ê½âÊÍ G#NbLj`h
1. ¿¹Ô³ÊµÝ 2. µ÷Àí×÷Óà 3. ³Áµí·´Ó¦ 4. ×ÔÉíÃâÒß XJl
3\*
5. GVHR 6. ÔìѪ¸Éϸ°û 7. ¿Ë¡ѡÔñѧ˵ 8. Ir»ùÒò g co;8e_
9. ³¬Ãô·´Ó¦ 10. ³¬¿¹Ô y!S:d
¶þ¡¢ÎÊ´ðÌâ 4/3w
*
11. ¼òÊö²¹ÌåµÄÅÔ·¼¤»î;¾¶ Unt]=S3u
12. ¼òÊöT¡¢Bϸ°ûÌØÕ÷µÄ²îÒì kDRxu!/
13. ¼òÊöT¡¢Bϸ°û¿¹Ô¾ö¶¨´ØµÄ²îÒì {A
,
w%
14. ΪʲôÃâÒßÇòµ°°×¾ßÓп¹ÔÐÔ£¿ÊÔÊöÃâÒßÇòµ°°×µÄ¿¹ÔÐÔ¡£ 9X#]Lg?b
15. ʲôÊÇÖ×Áö¿¹Ô£¿ÊÔÊö»úÌåÕë¶ÔÖ×Áö¿¹Ô²úÉú¿¹Ö×ÁöÃâÒßÓ¦´ðµÄ»úÖÆ¡£ '@.Lg0`
\>.[QQVI"l